Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
2 hedge funds and large institutions have $12K invested in Adial Pharmaceuticals Warrant in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.75K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.75K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10K | +$7.75K | +18,069 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$1.75K | +4,080 | +408,000% |
|
ADILW Hedge Fund Activity: Q4 2018 in Review
2 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q4 2018, worth a combined $12K.
Buyers outnumbered sellers: 1 fund opened new ADILW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.75K.
- 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q4 2018, up from 1 in Q3 2018.
- Funds reported $12K of Adial Pharmaceuticals Warrant stock for Q4 2018.
- 1 fund opened new Adial Pharmaceuticals Warrant positions in Q4 2018 and 0 closed out, a net change of +1 holder.
- The largest Adial Pharmaceuticals Warrant buyer in Q4 2018 was Susquehanna International Group, an estimated $7.75K added.
Based on aggregated 13F filings for Q4 2018.